Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amendment of Phase 1 Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults

NCT02971670 is registered in ClinicalTrials.gov with Biomedizinische Forschungs gmbH as lead sponsor.

NCT NCT02971670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02971670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amendment of Phase 1 Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults
Lead sponsor
Biomedizinische Forschungs gmbH
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
May 31, 2016
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, toxic-shock syndrome